JPMorgan analyst Jeffrey Zekauskas upgraded Ashland (ASH) to Overweight from Neutral with a price target of $71, up from $68. Ashland is a mostly non-cyclical specialty company that has fallen in value because of negative earnings momentum following a period of customer de-stocking, the analyst tells investors in a research note. The firm views the weakness in Ashland’s businesses as more transient rather than structural. JPMorgan believes the company’s businesses is “generally stabilizing.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASH: